These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 32342519

  • 21. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W, Ye Z, Chen L, Liang H, Cai Q.
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [Abstract] [Full Text] [Related]

  • 22. Deep learning-based model for predicting progression in patients with head and neck squamous cell carcinoma.
    Zhao Z, Li Y, Wu Y, Chen R.
    Cancer Biomark; 2020 Dec; 27(1):19-28. PubMed ID: 31658045
    [Abstract] [Full Text] [Related]

  • 23. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K, Nohata N, Hanazawa T, Kikkawa N, Arai T, Okato A, Fukumoto I, Katada K, Okamoto Y, Seki N.
    Oncotarget; 2017 May 02; 8(18):30288-30304. PubMed ID: 28415821
    [Abstract] [Full Text] [Related]

  • 24. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X, Li M, Hu J, Chen Z, Yu J, Dong Y, Sun C, Han J.
    J Cancer Res Ther; 2018 May 02; 14(7):1525-1534. PubMed ID: 30589034
    [Abstract] [Full Text] [Related]

  • 25. Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.
    Zhao X, Cui L.
    Am J Cancer Res; 2019 May 02; 9(10):2156-2169. PubMed ID: 31720080
    [Abstract] [Full Text] [Related]

  • 26. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
    Xu L, Li YY, Zhang YC, Wu YX, Guo DD, Long D, Liu ZH.
    Dis Markers; 2021 May 02; 2021():5759927. PubMed ID: 34853622
    [Abstract] [Full Text] [Related]

  • 27. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A, Matiur Rahaman M, Chen M, Tang X.
    BMC Cancer; 2018 Jan 06; 18(1):46. PubMed ID: 29306329
    [Abstract] [Full Text] [Related]

  • 28. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
    Zhou H, He Y, Li L, Wu C, Hu G.
    Int J Med Sci; 2021 Jan 06; 18(5):1297-1311. PubMed ID: 33526991
    [Abstract] [Full Text] [Related]

  • 29. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y, Yan Z, Lian S, Wei L, Zhou C, Feng D, Zhang Y, Yang J, Li M, Chen Y.
    J Immunother Cancer; 2020 Jul 06; 8(2):. PubMed ID: 32719094
    [Abstract] [Full Text] [Related]

  • 30. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
    Zhong Q, Zhou L, Zhu D.
    J Oral Pathol Med; 2021 Oct 06; 50(9):891-901. PubMed ID: 33880801
    [Abstract] [Full Text] [Related]

  • 31. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
    Lin C, Chen Y, Pan J, Lu Q, Ji P, Lin S, Liu C, Lin S, Li M, Zong J.
    BMC Genomics; 2023 Apr 28; 24(1):221. PubMed ID: 37106442
    [Abstract] [Full Text] [Related]

  • 32. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
    Shi H, Chen J, Li Y, Li G, Zhong R, Du D, Meng R, Kong W, Lu M.
    Oncotarget; 2016 Apr 19; 7(16):21579-90. PubMed ID: 26933913
    [Abstract] [Full Text] [Related]

  • 33. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
    Yang K, Zhang S, Zhang D, Tao Q, Zhang T, Liu G, Liu X, Zhao T.
    Int J Clin Oncol; 2019 Sep 19; 24(9):1030-1041. PubMed ID: 30937621
    [Abstract] [Full Text] [Related]

  • 34. Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma.
    Koma A, Asai S, Minemura C, Oshima S, Kinoshita T, Kikkawa N, Koshizuka K, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
    Int J Mol Sci; 2021 Sep 14; 22(18):. PubMed ID: 34576110
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS, Wei MQ, Nikolarakos D, Good D, Nair RG.
    PLoS One; 2020 Sep 14; 15(3):e0221779. PubMed ID: 32208417
    [Abstract] [Full Text] [Related]

  • 38. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma.
    Liu G, Zheng J, Zhuang L, Lv Y, Zhu G, Pi L, Wang J, Chen C, Li Z, Liu J, Chen L, Cai G, Zhang X.
    Sci Rep; 2018 Oct 15; 8(1):15250. PubMed ID: 30323196
    [Abstract] [Full Text] [Related]

  • 39. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
    Qi CL, Sheng JF, Huang ML, Zou Y, Wang YP, Wang F, Zeng F, Hua QQ, Chen SM.
    Medicine (Baltimore); 2021 Feb 12; 100(6):e24618. PubMed ID: 33578572
    [Abstract] [Full Text] [Related]

  • 40. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
    Shen Y, Liu J, Zhang L, Dong S, Zhang J, Liu Y, Zhou H, Dong W.
    Biomed Res Int; 2019 Feb 12; 2019():7376034. PubMed ID: 31485443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.